EW

Edwards Lifesciences Corp
NYSE
86.85
+0.56
+0.65%
After Hours: 86.87 +0.02 +0.02% 16:41 12/26 EST
OPEN
86.41
PREV CLOSE
86.29
HIGH
86.87
LOW
85.80
VOLUME
914.93K
TURNOVER
--
52 WEEK HIGH
87.89
52 WEEK LOW
65.94
MARKET CAP
50.40B
P/E (TTM)
37.34
1D
5D
1M
3M
1Y
5Y
1D
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
NASDAQ · 2d ago
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
NASDAQ · 4d ago
The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences
NASDAQ · 5d ago
Edwards Lifesciences wins FDA nod for SAPIEN M3 TMVR system
Seeking Alpha · 5d ago
Edwards Lifesciences receives FDA approval for SAPIEN M3 mitral valve system
TipRanks · 5d ago
Edwards Lifesciences Says FDA Approves SAPIEN M3 Mitral Valve Replacement System For Treatment Of Mitral Regurgitation
Benzinga · 5d ago
Edwards Lifesciences Advances Smart Surgery Monitoring With Completed SMART TRENDS Study
TipRanks · 6d ago
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026
NASDAQ · 6d ago
More
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

Webull offers Edwards Lifesciences Corp stock information, including NYSE: EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.